In this webinar, we bring a global perspective that will challenge the current Gold Standard of treatment.  Dr. Watanabe from Japan, will share the results of JCOG0802 which have been recently reported on AATS. Dr. Harvey Pass of the U.S. will share the design of CALGB140503, the results of which will be released next year, and Dr. Fang from China, will moderate the discussion following the presentations.

Will these two studies change the future of treatment of lung cancer and challenge the Gold Standard?
 
In addition, we will have a panel discussion on the strategy for the treatment of early lung cancer, with a broad overview on how these changes might impact patients, surgical care teams and surgical societies. This discussion will be focusing on these new studies, the evidence generated and the experts' views on it. 

This session is moderated by Dr. Anand Shastri, Thoracic Surgeon and the Senior Director, Medical and Clinical Affairs for Johnson and Johnson India, and for Ethicon, Asia Pacific.

The medical devices mentioned in this presentation are for illustrative purpose only. Not all products are licensed or available in all Asia Pacific and EMEA countries. This publication is not intended for distribution outside of the Asia Pacific and EMEA region. The third-party trademarks used herein are the trademarks of the respective owners.

213111-220510

販売名：パワードエシェロンフレックス７　　認証番号：227AABZX00087000

販売名：パワードエシェロンフレックス７カートリッジ　　承認番号：22700BZX00290000

販売名：ＧＳＴカートリッジ　　承認番号：22700BZX00155000

販売名：エンドスコピック　パワード　リニヤー　カッター　　認証番号：22500BZX00396000

販売名：バイクリル　　承認番号：15700BZY01341000

Lung cancer is the deadliest cancer worldwide and the most common cancer in Asia. In fact, 59% of all lung cancer cases occur in Asia and furthermore, 21% of all cancer related deaths in Asia are because of lung cancer. In addition, approximately one third of all lung cancer patients in East Asia are non-smokers. The treatment of lung cancer is evolving rapidly, and current evidence is beginning to show that new approaches for thoracic procedures and treatments have excellent outcomes and quality of life related results. Advances in diagnostic methods, earlier diagnosis and the important requirement of preserving as much lung function as possible, have made lung cancer surgery evolve to become as Minimally Invasive as possible and hence, has led to the widespread adoption of VATS and Uniportal VATS in Asia. In addition, lung function preserving operations such as segmentectomy and sub lobar radical resections also have a high interest in Asia Pacific and are being adopted as a new procedure strategy. 
 
There are two big studies that are being conducted in Japan (JCOG0802) and in the US(CALGB140503), on the oncological outcomes of VATS segmentectomy and its comparison with the more traditional VATS lobectomy. This is the first episode of our exciting series of two live webinars, where thoracic experts from Asia Pacific will share their clinical experiences, and practical techniques on VATS segmentectomy. This discussion on surgical methods, pros and cons will be underpinned with the latest evidence available. 

The medical devices mentioned in this presentation are for illustrative purpose only. Not all products are licensed or available in all Asia Pacific and EMEA countries. This publication is not intended for distribution outside of the Asia Pacific and EMEA region. The third-party trademarks used herein are the trademarks of the respective owners.

213079-220510 

販売名：エンドパス　エンドカッター　ＥＣ４５　　承認番号：22100BZX00089000

販売名：エンドカッター　　承認番号：21900BZX00881000

販売名：パワードエシェロンフレックス７　　認証番号：227AABZX00087000

販売名：パワードエシェロンフレックス７カートリッジ　　承認番号：22700BZX00290000

販売名：ＧＳＴカートリッジ　　承認番号：22700BZX00155000

With the rapid evolvement of percutaneous coronary interventions, the number of CABGs performed has continuously decreased over the past decades. There is a strong need for sustained efforts in the surgical arena towards the continuous optimization of CABG. In this session, hear from our experts on how they are working towards optimizing CABG in their practice.

This session is moderated by Dr. Anand Shastri, Thoracic Surgeon and the Senior Director, Medical and Clinical Affairs for Johnson and Johnson India, and for Ethicon, Asia Pacific.

*The cue points for this video is currently unavailable. We apologize for the inconvenience caused*

214411-220521

販売名：ハーモニック　ＦＯＣＵＳ　プラス 承認番号：22700BZX00411000

販売名：プロリーン　　承認番号：15300BZY01464000

販売名：バイクリル　　承認番号：15700BZY01341000

販売名：ＳＴＲＡＴＡＦＩＸ　Ｓｐｉｒａｌ　ＰＤＳ　プラス　　承認番号：22900BZX00123000

Colorectal   cancer   is   the   third   most   malignant   disease   in   Asia   and   approximately  700K*  colorectal  procedures  take  place  per  annum  in  the  APAC region. Additionally, colorectal surgery in APAC is growing 5.6%* and by 2023 surgeons in China, Korea, Taiwan, SEA, India, ANZ and Japan are predicted to complete more colorectal procedures* than EMEA, North and South America combined. Mitigating colorectal anastomotic complications is  at  the  centre  of  attention  of  the  Ethicon  team.  Our  strong  research,  technology, evidence and education are always most important for us but in addition,  we  strongly  believe  that  we  must  also  play  a  leadership  role  in  partnering  with  leading  faculties  to  improve  outcomes  for  patients  in  colorectal  surgery  by  sharing  their  best  practices  with  as  many  surgeons  as possible.

This session is moderated by Dr. Anand Shastri, Thoracic surgeon and the Senior Director, Medical and Clinical Affairs for Johnson and Johnson India, and for Ethicon, Asia Pacific.

*Source – Ethicon GBI procedure estimates of colectomies and rectal resections in APAC

*The cue points for this video is currently unavailable. We apologize for the inconvenience caused*

213520-220514

販売名：ＧＳＴカートリッジ　　                                             承認番号：22700BZX00155000

販売名：エンドスコピック　パワード　リニヤー　カッター　　認証番号：22500BZX00396000

販売名：エシェロン サーキュラー パワードステイプラー           承認番号：30100BZX00156000

販売名：エンドパス　エンドサーキュラーステイプラー       　　承認番号：21900BZX00880000

販売名：エンドパス　トロッカーシステム　　                          認証番号：21900BZX00882000

販売名：リガクリップ　内視鏡手術用　アプライヤー　          　承認番号：21900BZX00883000

販売名：ハーモニック　ＡＣＥ　プラス　　                             承認番号：22600BZX00425000

販売名：ハーモニック　ＨＤ　１０００ｉ　                          　承認番号：22900BZX00116000

Improving clinical outcomes in rectal cancer surgery is an important topic. In this regard, it can be said that it is essential to increase the accuracy of the dissection and ensure that anastomotic leakage is prevented. Discover more on how Dr Takemasa from Japan tackles the surgical challenges through techniques of dissection and reconstruction. In this webinar, you will learn about safe and efficient dissection with a focus on total mesorectal excision (TME), as well as tips on double stapling technique (DST) anastomosis and pitfalls to prevent anastomotic leakage.

219858-220706

販売名：ＧＳＴカートリッジ　　承認番号：22700BZX00155000

販売名：エンドスコピック　リニヤー　カッター　　認証番号：222AABZX00147000

販売名：エシェロン サーキュラー パワードステイプラー 承認番号：30100BZX00156000

販売名：リガクリップ　内視鏡手術用　アプライヤー　　承認番号：21900BZX00883000

販売名：エンドパス　サージェリー　プローブ　　認証番号：20400BZY00641000

販売名：ハーモニック　ＡＣＥ　プラス　　承認番号：22600BZX00425000

販売名：ハーモニック　ＨＤ　１０００ｉ　　承認番号：22900BZX00116000

販売名：エンドループ　ＰＤＳⅡ　　承認番号：20300BZY00934000

There is only one straight access from the utility port to the target structure, and this straight access should be reserved for operator's right hand, to ensure the maximum degree of freedom and safety.​ For any experienced single port surgeon, the best instrument setting will be Harmonic HD1000i in operator’s right hand for sharp dissection, and long curved sucker in operator’s left hand for suction/traction/blunt dissection. ​Find out more on the key points of the surgical procedure of single port VATS lobectomy with Dr Liu Chia-Chuan. 

219859-220706

販売名：エンドスコピック　リニヤー　カッター　　認証番号：222AABZX00147000

販売名：エンドスコピック　パワード　リニヤー　カッター　４５　　認証番号：225AABZX00227000

販売名：ハーモニック　ＨＤ　１０００ｉ　　承認番号：22900BZX00116000